Anaphylaxis to Mivacurium

Anaesthesia and Intensive Care

Volumn 24, Issue 4, 1996, Pages 486-488

  Baird, M B ^a   Futter, M ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Muscle relaxants: nondepolarizing, mivacurium, anaphylaxis, adverse effects

Indexed keywords

AUTACOID; CHYMASE; CHYMASE 2; ISOQUINOLINE DERIVATIVE; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT; SERINE PROTEINASE; TRYPTASE;

ANAPHYLAXIS; ARTICLE; BLOOD; CASE REPORT; CHEMICALLY INDUCED DISORDER; CHILD; HUMAN; MALE;

ANAPHYLAXIS; CHILD; CHYMASES; HUMANS; INFLAMMATION MEDIATORS; ISOQUINOLINES; MALE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; SERINE ENDOPEPTIDASES; TRYPTASES;

EID: 0030203866     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x9602400413     Document Type: Article

References (11)

1. Fisher MM. Tryptase in anaphylaxis. Anaesth Intens Care 1991; 19(3):479.
2. Schwartz LB, Metcalfe D, Miller J, Earle H, Sullivan T. Tryptase levels as an indicator of mast cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987; 316:1622-1626.
3. Watkins J. Adverse reaction to neuromuscular blockers: frequency, investigation, and epidemiology. Acta Anaesthesiol Scand 1994; 38(Suppl 102):6-10.
4. Fisher M. Intradermal testing after anaphylactoid reaction to anaesthetic drugs: Practical aspects of performance and interpretation. Anaesth Intens Care 1984; 12:115-120.
5. Fisher MM, Baldo BA. The incidence and clinical features of anaphylactic reactions during anaesthesia in Australia. Ann Fr Anesth Reanim 1993; 12(2):97-104.
6. Pepys J, Pepys EO, Baldo BA, Whitwam JG. Anaphylactic/anaphylactoid reactions to anaesthetic and associated agents. Skin prick tests in aetiological diagnosis. Anaesthesia 1994; 49(6):470-475.
7. Laxenaire MC. Drugs and other agents involved in anaphylactic shock occurring during anaesthesia. A French multicenter epidemiological inquiry. Ann Fr Anesth Reanim 1993; 12(2): 91-96.
8. Savarese JJ, Hassan HA, Basta SJ, et al. The cardiovascular effects of mivacurium chloride in patients receiving nitrous oxide-opiate-barbiturate anaesthesia. Anaesthesiology 1989; 70:386-394.
9. UK Prescribing Information, Mivacurium, The Wellcome Foundation, 1993.
10. Basta SJ, Savarese JJ, Ali HH, Moss J, Gionfriddo M. Histamine releasing potencies of atracurium, dimethyl tubocurarine and tubocurarine. Br J Anaesth 1983; 55:105-1065.
11. Scott RPF, Savarese JJ, et al. Atracurium: Clinical strategies for preventing histamine release and attenuating the haemodynamic response. Br J Anaesth 1985; 57:550-553.